Edition:
India

Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

41.63USD
25 Mar 2019
Change (% chg)

-- (--)
Prev Close
$41.63
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
218,166
52-wk High
$79.30
52-wk Low
$33.06

About

Esperion Therapeutics, Inc. is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). With a targeted mechanism of action, bempedoic acid, the... (more)

Overall

Beta: 2.67
Market Cap(Mil.): $1,444.21
Shares Outstanding(Mil.): 25.69
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates